Actemra
Disease-Modifying Antirheumatic Agent
Tocilizumab, Preservative Free
80 mg / 4 mL Intravenous Injection
Single Use Vial 4 mL
Genentech 50242013501

Actemra
Disease-Modifying Antirheumatic Agent
Tocilizumab, Preservative Free
80 mg / 4 mL Intravenous Injection
Single Use Vial 4 mL
Genentech 50242013501

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 50242013501 Brand ActemraŽ Manufacturer Genentech USA Application Disease-Modifying Antirheumatic Agent Container Type Single Use Vial Dosage Form Injection Generic Drug Code 27366 Generic Drug Name Tocilizumab, Preservative Free NDC Number 50242-0135-01 Strength 80 mg / 4 mL Type Intravenous Volume 4 mL Features

ACTEMRA (tocilizumab) is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1? (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure ACTEMRA is supplied as a sterile, preservative-free solution for intravenous (IV) infusion at a concentration of 20 mg per mL